Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jun 6 2022

Full Issue

Restarted Abbott Plant Prioritizing Formula For Babies With Digestive Issues

Abbott Nutrition resumed production Saturday at its Sturgis, Michigan, facility, after the Food and Drug Administration said that "initial requirements" were met in addressing sanitary violations. Elecare, a specialty formula for infants with severe allergies or digestive issues, is the first product on the line and should start shipping June 20.

CNBC: Abbott Nutrition Restarts Baby Formula Production In Reopened Michigan Plant

Abbott Nutrition on Saturday resumed baby formula production at its Sturgis, Michigan, plant, a move toward addressing a nationwide shortage. The company has been given the green light from the U.S. Food and Drug Administration after meeting “initial requirements” as part of a May 16 consent decree. The company said it will restart the production of EleCare, a formula for children who struggle to digest other products, along with other specialty and metabolic formulas. (Dore, 6/4)

AP: Abbott Restarts Baby Formula Plant Linked To Contamination

Abbott said it initially will prioritize production of its EleCare specialty formulas for infants with severe food allergies and digestive problems who have few other options for nutrition. The company said it will take about three weeks before new formula from the plant begins getting to consumers. “We will ramp production as quickly as we can while meeting all requirements,” Abbott said in a statement. (Perrone, 6/4)

Fox News: US To Import Baby Formula From Mexico, But Parents Must Wait Until July To Buy It

In a Friday update, the U.S. Food and Drug Administration (FDA) said that about 1.3 million cans of Gerber Good Start Gentle infant formula would be imported from Mexico to the U.S. The shipment of nearly 33 million full-size, 8-ounce bottles – or 2.2 million pounds – is expected to be available from Nestlé on Gerber's website and at key retailers starting in July and extending through October. "The FDA is exercising enforcement discretion for the importation of Gerber Good Start Gentle from Nestlé (Mexico) following the review of info provided pertaining to nutritional adequacy and safety including testing, labeling and facility production [and] inspection history," the agency tweeted. (Musto, 6/3)

The Hill: Commerce Secretary Says She ‘Probably’ Didn’t Learn Of Baby Formula Shortage Until April 

Commerce Secretary Gina Raimondo said on Sunday that the Biden administration has taken “extraordinary” measures to combat the ongoing baby formula shortage, but when pressed said she “probably” didn’t learn about the crisis until April. “I first learned about it a couple of months ago,” Raimondo told CNN “State of the Union” co-anchor Jake Tapper. But when Tapper followed up by asking if she had first learned about it in April — the same time President Biden recently revealed he learned about the severity of the crisis — Raimondo said, “probably.” (Schonfeld, 6/5)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF